{
     "PMID": "10828741",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20000822",
     "LR": "20171101",
     "IS": "0031-7012 (Print) 0031-7012 (Linking)",
     "VI": "60",
     "IP": "4",
     "DP": "2000 May",
     "TI": "2-Oxo-2H-Pyrimido[2,1-b]benzothiazoles inhibit brain benzodiazepine receptor binding in vitro.",
     "PG": "175-8",
     "AB": "2-Oxo-2H-pyrimido[2,1-b]benzothiazole derivatives were found to inhibit the in vitro binding of (3)H-Ro 15-1788 ((3)H-flumazenil) to rat cortical benzodiazepine receptors with IC(50) values in the range of 0.7-13 micromol/l. The most potent compound, 2-oxo-4-phenyl-2H-pyrimido[2,1-b]- benzothiazole showed a similar potency to inhibit (3)H-Ro 15-1788 binding to membrane preparations of rat brain cortex, cerebellum and hippocampus as well as to various subunit combinations of recombinant human gamma-aminobutyric acid(A)/benzodiazepine receptors. Scatchard plot analysis showed that 2-oxo-4-phenyl-2H-pyrimido[2,1-b]benzothiazole is a competitive inhibitor of (3)H-Ro 15-1788 binding to rat brain cortical membrane preparations.",
     "CI": [
          "Copyright 2000 S. Karger AG, Basel"
     ],
     "FAU": [
          "Ai, J",
          "Wang, X",
          "Wahe, H",
          "Fomum, Z T",
          "Sterner, O",
          "Nielsen, M",
          "Witt, M R"
     ],
     "AU": [
          "Ai J",
          "Wang X",
          "Wahe H",
          "Fomum ZT",
          "Sterner O",
          "Nielsen M",
          "Witt MR"
     ],
     "AD": "Department of Psychopharmacology, Research Institute of Biological Psychiatry, Sct. Hans Hospital, Roskilde, Denmark. jinglu.ai@shh.hosp.dk",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Switzerland",
     "TA": "Pharmacology",
     "JT": "Pharmacology",
     "JID": "0152016",
     "RN": [
          "0 (Benzothiazoles)",
          "0 (GABA Modulators)",
          "0 (Receptors, GABA-A)",
          "0 (Thiazoles)",
          "40P7XK9392 (Flumazenil)",
          "G5BW2593EP (benzothiazole)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Benzothiazoles",
          "Brain/*metabolism",
          "Flumazenil/*metabolism",
          "GABA Modulators/*metabolism",
          "Humans",
          "Male",
          "Rats",
          "Rats, Wistar",
          "Receptors, GABA-A/*metabolism",
          "Thiazoles/*metabolism"
     ],
     "EDAT": "2000/06/01 09:00",
     "MHDA": "2000/08/29 11:01",
     "CRDT": [
          "2000/06/01 09:00"
     ],
     "PHST": [
          "2000/06/01 09:00 [pubmed]",
          "2000/08/29 11:01 [medline]",
          "2000/06/01 09:00 [entrez]"
     ],
     "AID": [
          "28366 [pii]",
          "10.1159/000028366 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Pharmacology. 2000 May;60(4):175-8. doi: 10.1159/000028366.",
     "term": "hippocampus"
}